News ResMed, Inc.

Equities

RMD

US7611521078

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 02:30:02 12/12/2025 am IST			5-day change	1st Jan Change
252.39 ^USD	+0.35%		+0.35%	+10.36%

10/12	Resmed Insider Sold Shares Worth $1,254,796, According to a Recent SEC Filing	MT
09/12	Shares of Resmed Fall After Securing FDA Clearance for a Device Recommending Personalized Comfort Settings	MT

Resmed Insider Sold Shares Worth $1,254,796, According to a Recent SEC Filing	10/12	MT
Shares of Resmed Fall After Securing FDA Clearance for a Device Recommending Personalized Comfort Settings	09/12	MT
ResMed Receives FDA Clearance for AI-Powered Device to Personalize Sleep Apnea Therapy	08/12	MT
Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy	08/12	GL
Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy	08/12	AQ
Resmed, Inc. Receives FDA Clearance for Personalized Therapy Comfort Settings, to Be Marketed as Smart Comfort	08/12	CI
Resmed Insider Sold Shares Worth $502,940, According to a Recent SEC Filing	05/12	MT
LivaNova PLC Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea, Effective December 1, 2025	02/12	CI
Major Breakthrough in At Home Sleep Therapy: ResMed Launches "AirCurve 11 VAuto" to Improve Sleep Apnea Treatment Comfort and Compliance	28/11	AQ
ResMed Inc. Announces Not Seek Re-Election of Richard Sulpizio to the Board of Directors, Effective November 19, 2025	26/11	CI
UK financial sector makes slow progress on preparations for new settlement system	25/11	RE
ResMed : Statement of Changes in Beneficial Ownership (Form 4)	24/11	PU
ResMed : Statement of Changes in Beneficial Ownership (Form 4)	24/11	PU
ResMed : Statement of Changes in Beneficial Ownership (Form 4)	24/11	PU
Ex-dividend day	13/11	FA
ResMed Insider Sold Shares Worth $2,000,773, According to a Recent SEC Filing	11/11	MT
ResMed CFO Sells Shares	05/11	MT
ResMed CFO Buys, Sells Shares	05/11	MT
Resmed Insider Sold Shares Worth $742,620, According to a Recent SEC Filing	05/11	MT
ResMed CFO Sells Shares	04/11	MT
ASX Biggest Losers	03/11	MT
ASX Midday Sector Update: Information Technology Stocks Rise, Healthcare Down	03/11	MT
Baird Adjusts Price Target on ResMed to $300 From $320	31/10	MT
Jefferies & Co Adjusts ResMed Price Target to $285 From $290	31/10	MT
Wells Fargo Adjusts ResMed Price Target to $265 From $280	31/10	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ResMed's innovation-driven success and prospects

October 31, 2025 at 02:25 pm IST